Evidence map›Paper›PMID 40999489›Full record

ReviewChinese medical journal2025

Computational pathology in precision oncology: Evolution from task-specific models to foundation models.

Yuhao Wang, Yunjie Gu, Xueyuan Zhang, Baizhi Wang, Rundong Wang, Xiaolong Li, Yudong Liu, Fengmei Qu, Fei Ren, Rui Yan and 1 more

Abstract readReview
In one paragraph

Review in Chinese medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuhao WangSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
Yunjie GuSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
Xueyuan ZhangChongqing Zhijian Life Technology Co., Ltd., Chongqing 400039, China.
Baizhi WangSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
Rundong WangSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
Xiaolong LiSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
Yudong LiuState Key Lab of Processors, Institute of Computing Technology, CAS, Beijing 100190, China.
Fengmei QuJinfeng Laboratory, Chongqing 401329, China.
Fei RenState Key Lab of Processors, Institute of Computing Technology, CAS, Beijing 100190, China.
Rui YanSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.
S Kevin ZhouSchool of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui, Hefei 230026, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractWith the rapid development of artificial intelligence, computational pathology has been seamlessly integrated into the entire clinical workflow, which encompasses diagnosis, treatment, prognosis, and biomarker discovery. This integration has significantly enhanced clinical accuracy and efficiency while reducing the workload for clinicians. Traditionally, research in this field has depended on the collection and labeling of large datasets for specific tasks, followed by the development of task-specific computational pathology models. However, this approach is labor intensive and does not scale efficiently for open-set identification or rare diseases. Given the diversity of clinical tasks, training individual models from scratch to address the whole spectrum of clinical tasks in the pathology workflow is impractical, which highlights the urgent need to transition from task-specific models to foundation models (FMs). In recent years, pathological FMs have proliferated. These FMs can be classified into three categories, namely, pathology image FMs, pathology image-text FMs, and pathology image-gene FMs, each of which results in distinct functionalities and application scenarios. This review provides an overview of the latest research advancements in pathological FMs, with a particular emphasis on their applications in oncology. The key challenges and opportunities presented by pathological FMs in precision oncology are also explored.

Indexed as

Computational BiologyMedical OncologyPrecision MedicineArtificial IntelligenceHumansNeoplasmsArtificial intelligenceComputational pathologyDeep learningFoundation modelsPrecision oncology

Identifiers

PMID40999489
PMCPMC12634262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.